No­var­tis re­it­er­ates its faith in Eylea ri­val Beovu; An­ti-NGF drug from Lil­ly, Pfiz­er is ac­cept­ed for FDA re­view

→ Last month, the Chica­go-based Amer­i­can So­ci­ety of Reti­na Spe­cial­ists high­light­ed 14 cas­es of reti­nal vas­culi­tis that have re­cent­ly emerged …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.